Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine vs lamotrigine add-on to lithium for anxiety symptoms in remitting bipolar patients
2005-001606-66Phase 4Active
- Sponsor
- AOU Città della Salute e della Scienza di Torino
- Start
- Jul 2005
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of olanzapine, lamotrigine and lithium in bipolar disorder (BD) (2 arms), sponsored by AOU Città della Salute e della Scienza di Torino. Started Jul 2005; status: active.
02
Drugs
olanzapinelamotriginelithium
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on 2005-001606-66.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001606-66.